Cargando…

Vaccine immunotherapy with ARNAX induces tumor‐specific memory T cells and durable anti‐tumor immunity in mouse models

Immunological checkpoint blockade therapies benefit a limited population of cancer patients. We have previously shown that vaccine immunotherapy with Toll‐like receptor (TLR)3‐adjuvant and tumor antigen overcomes anti‐programmed death ligand‐1 (PD‐L1) resistance in mouse tumor models. In the present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeda, Yohei, Yoshida, Sumito, Takashima, Ken, Ishii‐Mugikura, Noriko, Shime, Hiroaki, Seya, Tsukasa, Matsumoto, Misako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029830/ https://www.ncbi.nlm.nih.gov/pubmed/29791768 http://dx.doi.org/10.1111/cas.13649

Ejemplares similares

Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy
por: Yoshida, Sumito, et al.
Publicado: (2019)

Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
por: Shime, Hiroaki, et al.
Publicado: (2017)

Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy
por: SEYA, Tsukasa, et al.
Publicado: (2018)

Toll‐like receptor 3 signal augments radiation‐induced tumor growth retardation in a murine model
por: Yoshida, Sumito, et al.
Publicado: (2018)

Adjuvant for vaccine immunotherapy of cancer – focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity
por: Seya, Tsukasa, et al.
Publicado: (2015)

The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in Apc(Min/+) mice
por: Ono, Junya, et al.
Publicado: (2017)

TAMable tumor-associated macrophages in response to innate RNA sensing
por: Seya, Tsukasa, et al.
Publicado: (2012)

The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages
por: Yoshida, Sumito, et al.
Publicado: (2017)

Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide
por: Takeda, Yohei, et al.
Publicado: (2018)

TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis
por: Seya, Tsukasa, et al.
Publicado: (2012)

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
por: Matsumoto, Misako, et al.
Publicado: (2017)

Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy
por: Takeda, Yohei, et al.
Publicado: (2016)

Development of Mouse Hepatocyte Lines Permissive for Hepatitis C Virus (HCV)
por: Aly, Hussein Hassan, et al.
Publicado: (2011)

TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review
por: Komal, Asma, et al.
Publicado: (2021)

Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells
por: Kasamatsu, Jun, et al.
Publicado: (2016)

Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement
por: Seya, Tsukasa, et al.
Publicado: (2022)

The second and third amino acids of Pam2 lipopeptides are key for the proliferation of cytotoxic T cells
por: Takeda, Yohei, et al.
Publicado: (2018)

TLR2-Dependent Induction of IL-10 and Foxp3(+)CD25(+)CD4(+) Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo
por: Yamazaki, Sayuri, et al.
Publicado: (2011)

cGAMP Promotes Germinal Center Formation and Production of IgA in Nasal-Associated Lymphoid Tissue
por: Takaki, Hiromi, et al.
Publicado: (2017)

Innate–Acquired Linkage in Immunotherapy
por: Seya, Tsukasa
Publicado: (2023)

Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies
por: Seya, Tsukasa, et al.
Publicado: (2006)

Pan-Vertebrate Toll-Like Receptors During Evolution
por: Oshiumi, Hiroyuki, et al.
Publicado: (2008)

A Distinct Role of Riplet-Mediated K63-Linked Polyubiquitination of the RIG-I Repressor Domain in Human Antiviral Innate Immune Responses
por: Oshiumi, Hiroyuki, et al.
Publicado: (2013)

Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination
por: Seya, Tsukasa, et al.
Publicado: (2023)

RIOK3 keeps MDA5 inactive
por: Takashima, Ken, et al.
Publicado: (2015)

Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells
por: Azuma, Masahiro, et al.
Publicado: (2012)

The dataset of proteins specifically interacted with activated TICAM-1
por: Funami, Kenji, et al.
Publicado: (2016)

Live imaging of transforming growth factor‐β activated kinase 1 activation in Lewis lung carcinoma 3LL cells implanted into syngeneic mice and treated with polyinosinic:polycytidylic acid
por: Takaoka, Saori, et al.
Publicado: (2016)

Nucleic Acid Sensors Involved in the Recognition of HBV in the Liver–Specific in vivo Transfection Mouse Models—Pattern Recognition Receptors and Sensors for HBV
por: Leong, Chean Ring, et al.
Publicado: (2015)

Levels of Complement Regulatory Molecules in Lung Cancer: Disappearance of the D17 Epitope of CD55 in Small‐cell Carcinoma
por: Sakuma, Takahiko, et al.
Publicado: (1993)

An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma
por: Ehira, Nobuyuki, et al.
Publicado: (2010)

Dendritic Cells from Oral Cavity Induce Foxp3(+) Regulatory T Cells upon Antigen Stimulation
por: Yamazaki, Sayuri, et al.
Publicado: (2012)

Correction: an embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma
por: Ehira, Nobuyuki, et al.
Publicado: (2014)

Cell Type-Specific Subcellular Localization of Phospho-TBK1 in Response to Cytoplasmic Viral DNA
por: Suzuki, Takayuki, et al.
Publicado: (2013)

UNC93B1 Physically Associates with Human TLR8 and Regulates TLR8-Mediated Signaling
por: Itoh, Hiroki, et al.
Publicado: (2011)

Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)
por: Nakai, Masato, et al.
Publicado: (2015)

Zyxin stabilizes RIG-I and MAVS interactions and promotes type I interferon response
por: Kouwaki, Takahisa, et al.
Publicado: (2017)

Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy
por: Ilyinskii, Petr O., et al.
Publicado: (2018)

Memory T cells: strategies for optimizing tumor immunotherapy
por: Liu, Qingjun, et al.
Publicado: (2020)

Identification of a polyI:C-inducible membrane protein that participates in dendritic cell–mediated natural killer cell activation
por: Ebihara, Takashi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u6il39fjhs396liemrm9c00p6i